Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications

European Journal of Endocrinology

Volumn 171, Issue 1, 2014, Pages 37-45

  Vassilatou, Evangeline ^a   Vryonidou, Andromachi ^b   Ioannidis, Dimitrios ^c   Paschou, Stavroula A ^b   Panagou, Maria ^c   Tzavara, Ioanna ^c  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c AMALIA FLEMING GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADRENAL INCIDENTALOMA; ADULT; AGED; ARTICLE; BILATERAL ADRENAL INCIDENTALOMA; CONTROLLED STUDY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNILATERAL ADRENAL INCIDENTALOMA;

ADRENAL GLAND NEOPLASMS; AGED; CUSHING SYNDROME; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84903542019     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0848     Document Type: Article

References (32)

1. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B. Incidentally discovered adrenal masses. Endocrine Reviews 1995 16 460-484.
2. Herrera MF, Grant CS, van Heerden JA, Sheedy PF & Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991 110 1014-1021.
3. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. Journal of Endocrinological Investigation 2006 29 298-302. (doi:10.1007/BF03344099)
4. Song JH, Chaudhry FS & Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,029 consecutive adrenal masses in patients with no known malignancy. AJR. American Journal of Roentgenology 2008 190 1163-1168. (doi:10.2214/AJR.07.2799)
5. Barzon L, Sonino N, Fallo F, Palu G & Boscaro M. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology 2002 146 61-66. (doi:10.1530/eje.0.1460061)
6. Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, Borretta G & Angeli A. Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinology and Metabolism Clinics of North America 2005 34 423-439. (doi:10.1016/j.ecl.2005.01. 008)
7. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B & Winkelmann W. Preclinical Cushing's syndrome in "adrenal incidentalomas": comparison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 826-832.
8. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V & Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 2000 85 1440-1448.
9. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G & Angeli A. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644.
10. Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C & Tzavara I. Hormonal activity of adrenal incidentalomas-results from a long term follow-up study. Clinical Endocrinology 2009 70 674-679. (doi:10.1111/j.1365-2265.2008.03492.x)
11. Arnaldi G & Boscaro M. Adrenal incidentaloma. Best Practice and Research. Clinical Endocrinology and Metabolism 2012 26 405-419. (doi:10.1016/j.beem.2011.12.006)
12. Zeiger MA, Siegelman SS & Hamrahian AH. Medical and surgical evaluation and treatment of adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 2011 96 2004-2015. (doi:10.1210/jc.2011-0085)
13. Majnik J, Patocs A, Balogh K, Toth M, Gergics P, Szappanos A, Mondok A, Borgulya G, Panczel P, Prohaszka Z et al. Overpresentation of the N363S variant of the glucocrticoid receptor gene in patients with bilateral adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 2006 91 2796-2799. (doi:10.1210/jc.2006-0066)
14. Patocs A, Toth M, Barta C, Sasvari-Szekely M, Varga I, Szucs N, Jakab C, Glaz E & Racz K. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. European Journal of Endocrinology 2002 147 349-355. (doi:10.1530/eje.0.1470349)
15. Vassiliadi DA, Ntali G, Vicha E & Tsagarakis S. High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clinical Endocrinology 2011 74 438-444. (doi:10.1111/j.1365-2265.2010.03963.x)
16. Androulakis I, Kaltsas G, Markou A, Tseniklidi E, Kafritsa P, Pappa T, Papanastasiou L & Piaditis G. The functional status of incidentally discovered bilateral adrenal lesions. Clinical Endocrinology 2011 75 44-49. (doi:10.1111/j.1365-2265.2011.04013.x)
17. Olsen H, Nordensrom E, Bergenfelz A, Nyman U, Valdemarsson S & Palmqvist E. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine 2012 42 164-173. (doi:10.1007/s12020-012-9622-2)
18. Morelli V, Palmieri S, Salcuni AS, Eller-Vainicher C, Cairoli E, Zhukouskaya V, Scillitani A, Beck-Peccoz P & Chiodini I. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. European Journal of Endocrinology 2013 168 235-241. (doi:10.1530/EJE-12-0777)
19. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-The evidence report. National Institutes of Health. Obesity Research 1998 6 (Suppl 2): 51S-209S
20. JNC VI. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Archives of Internal Medicine 1997 157 2413-2446. (doi:10.1001/archinte.1997.00440420033005)
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197.
22. National Cholesterol Educational Programm (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Educational Programm (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final Report. Circulation 2002 106 3143.
23. Young WF Jr, du Plessis H, Thompson GB, Grant CS, Farley DR, Richards ML, Erickson D, Vella A, Stanson AW, Carney JA et al. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World Journal of Surgery 2008 32 856-862. (doi:10.1007/s00268-007-9332-8)
24. Bourdeau I, D'Amour P, Hamet P, Boutin JM & Lacroix A. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 5534-5540.
25. Roussel HW, Vezzosi D, Rizk-Rabin M, Barreau O, Ragazzon B, René-Corail F, Reynies A, Bertherat J & Assie G. Identification of gene expression profiles associated with cortisol secretion in adrenocortical adenomas. Journal of Clinical Endocrinology and Metabolism 2013 98 E1109-E1121. (doi:10.1210/jc.2012-4237)
26. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Victor M & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)
27. Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P & Angeli A. Subclinical Cushing's syndrome in adrenal incidentaloma. Clinical Endocrinology 1998 48 89-97. (doi:10.1046/j.1365-2265.1998.00357.x)
28. Bernini GP, Moretti A, Oriandini C, Bardini M, Taurino C & Salvetti A. Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. British Journal of Cancer 2005 92 1104-1109. (doi:10.1038/sj.bjc.6602459)
29. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F & Ballotta E. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Annals of Surgery 2009 249 388-391. (doi:10.1097/SLA.0b013e31819a47d2)
30. Perysinakis I, Marakaki C, Avlonitis S, Katseli A, Vassilatou E, Papanastasiou L, Piaditis G & Zografos GN. Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome. Surgical Endoscopy 2013 27 2145-2148. (doi:10.1007/s00464-012-2730-5)
31. Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B & Salvetti A. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology 2003 148 213-219. (doi:10.1530/eje.0.1480213)
32. Chiodini I, Morelli V, Stefano Salcuni A, Eller-Vainicher C, Torlontano M, Coletti F, Lorio L, Cuttitta A, Ambrosio A, Vicentini L et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2010 95 2736-2745. (doi:10.1210/jc.2009-2387)